Novel inhibitors of herpes virus protease
2017/27/N/NZ6/02328
Keywords
Descriptors
- NZ6_5: Wirusologia
- NZ1_1: Biologia molekularna
- NZ1_2: Biochemia
Panel
NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution
Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 14 – announced on 2017-09-15
- Amount awarded
- 139 400 PLN
- Project start date
- 2018-07-26
- Project end date
- 2021-07-25
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- Komputer osobisty. Cost: 4 937 PLN
Information in the final report
Publication in academic press/journals (1)
-
Novel inhibitors of HSV-1 protease effective in vitro and in vivo
- Authors:
- Magdalena Pachota, Renata Grzywa, Jakub Iwanejko, Aleksandra Synowiec, Dominika Iwan, Karolina Kamińska, Marcin Skoreński, Ewa Bielecka, Krzysztof Szczubiałka, Maria Nowakowska, Cameron D. Mackereth, Elżbieta Wojaczyńska, Marcin Sieńczyk, Krzysztof Pyrć
- Academic press:
- Antivral Research (year: 2022, volume: 213, pages: 105604), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.antiviral.2023.105604 – link to the publication